barium sulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4346	7727-43-7

Description:

Molecule	Description
Synonyms: barium sulfate paste barium sulfate barium sulphate	A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield. Molecular weight: 233.38 Formula: BaO4S CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: 80.26 ALOGS: ROTB: None

Molecule

Description

Synonyms:

barium sulfate paste
barium sulfate
barium sulphate

A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.

Molecular weight: 233.38
Formula: BaO4S
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 80.26
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
None	FDA

FDA Adverse Event Reporting System (Female)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
No adverse event	116.03	48.89	28	238	41377	63447379

Showing 1 to 1 of 1 entries

Previous1Next

FDA Adverse Event Reporting System (Male)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
No adverse event	70.80	47.30	16	100	22911	34933904
Aspiration	62.83	47.30	13	103	12181	34944634

Showing 1 to 2 of 2 entries

Previous1Next

FDA Adverse Event Reporting System (Geriatric)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Aspiration	76.20	36.88	18	373	20140	79723857
Urticaria	59.55	36.88	25	366	185176	79558821
Barium impaction	44.92	36.88	4	387	0	79743997

Showing 1 to 3 of 3 entries

Previous1Next

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Show entries

Search:

Source	Code	Description
ATC	V08BA01	VARIOUS CONTRAST MEDIA X-RAY CONTRAST MEDIA, NON-IODINATED Barium sulfate containing X-ray contrast media
CHEBI has role	CHEBI:37338	contrast media
FDA EPC	N0000180185	Radiographic Contrast Agent
FDA MoA	N0000010258	X-Ray Contrast Activity
MeSH PA	D003287	Contrast Media
MeSH PA	D064907	Diagnostic Uses of Chemicals

Showing 1 to 6 of 6 entries

Previous1Next

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

Show entries

Search:

ID	Source
001100	NDDF
1331	RXNORM
24414	PUBCHEM_CID
25419009	SNOMEDCT_US
25BB7EKE2E	UNII
396014007	SNOMEDCT_US
4018191	VUID
4018191	VANDF
4245	MMSL
740	MMSL

Showing 1 to 10 of 18 entries

Previous1 2Next

Pharmaceutical products:

Show entries

Search:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
E-Z-Disk	HUMAN PRESCRIPTION DRUG LABEL	1	10361-778	TABLET	700 mg	ORAL	Unapproved drug other	17 sections
E-Z-Disk	HUMAN PRESCRIPTION DRUG LABEL	1	10361-778	TABLET	700 mg	ORAL	Unapproved drug other	17 sections
E-Z-HD	HUMAN PRESCRIPTION DRUG LABEL	1	32909-764	POWDER, FOR SUSPENSION	980 mg	ORAL	NDA	15 sections
E-Z-HD	HUMAN PRESCRIPTION DRUG LABEL	1	32909-764	POWDER, FOR SUSPENSION	980 mg	ORAL	NDA	15 sections
E-Z-Paque	HUMAN PRESCRIPTION DRUG LABEL	1	32909-186	SUSPENSION	0.60 g	ORAL	NDA	14 sections
E-Z-Paque	HUMAN PRESCRIPTION DRUG LABEL	1	32909-187	SUSPENSION	0.60 g	ORAL	NDA	14 sections
E-Z-Paque	HUMAN PRESCRIPTION DRUG LABEL	1	32909-750	POWDER, FOR SUSPENSION	960 mg	ORAL	NDA	14 sections
E-Z-Paque	HUMAN PRESCRIPTION DRUG LABEL	1	32909-750	POWDER, FOR SUSPENSION	960 mg	ORAL	NDA	14 sections
E-Z-Paste	HUMAN PRESCRIPTION DRUG LABEL	1	32909-770	CREAM	0.60 g	ORAL	Unapproved drug other	19 sections
ENTERO Vu 24%	HUMAN PRESCRIPTION DRUG LABEL	1	32909-145	SUSPENSION	240 mg	ORAL	NDA	20 sections

Showing 1 to 10 of 30 entries

Previous1 2 3Next